<?xml version="1.0" encoding="utf-8"?>
<feed xmlns:dc="http://dublincore.org/documents/dcmi-namespace/" xmlns:media="http://search.yahoo.com/mrss/" xmlns="http://www.w3.org/2005/Atom">
<title
type="text">Clover Health Investments, Corp.</title>
<subtitle
type="text">Contains the last 20 releases</subtitle>
<id>uuid:2e7c86fd-152f-4143-a5bb-2399e376deaf;id=41896</id>
<rights
type="text">Copyright 2024, Clover Health Investments, Corp.</rights>
<updated>2024-11-06T21:05:00Z</updated>
<author>
<name>newsdesk@globenewswire.com (NewsDesk)</name>
<uri>http://www.globenewswire.com/LegacyRss?Length=4</uri>
<email>newsdesk@globenewswire.com</email>
</author>
<link
rel="alternate"
href="https://www.globenewswire.com/atomfeed/organization/myjFNpMtjuT-wPiL8DMzXw==" />
<link
rel="self"
href="https://www.globenewswire.com/atomfeed/organization/myjFNpMtjuT-wPiL8DMzXw==" />
<entry>
<id>https://www.globenewswire.com/news-release/2024/11/06/2976057/0/en/Clover-Health-Reports-Strong-Third-Quarter-2024-Financial-Results-Highlights-Differentiated-Market-Opportunity-to-Grow-Membership.html</id>
<title
type="text">Clover Health Reports Strong Third Quarter 2024 Financial Results; Highlights Differentiated Market Opportunity to Grow Membership</title>
<published>2024-11-06T21:05:00Z</published>
<updated>2024-11-13T20:20:28Z</updated>
<link
rel="alternate"
href="https://www.globenewswire.com/news-release/2024/11/06/2976057/0/en/Clover-Health-Reports-Strong-Third-Quarter-2024-Financial-Results-Highlights-Differentiated-Market-Opportunity-to-Grow-Membership.html" />
<category
term="Nasdaq:CLOV"
scheme="https://www.globenewswire.com/rss/stock" />
<category
term="US18914F1030"
scheme="https://www.globenewswire.com/rss/ISIN" />
<content
type="html"><![CDATA[<p align="center"><em>Delivers 9% Total Revenue growth year-to-date compared to prior year period</em></p>]]></content>
<dc:identifier>2976057</dc:identifier>
<dc:language>en</dc:language>
<dc:publisher>GlobeNewswire Inc.</dc:publisher>
<dc:contributor>Clover Health Investments, Corp.</dc:contributor>
<dc:modified>Wed, 06 Nov 2024 21:05 GMT</dc:modified>
<dc:subject>Earnings Releases and Operating Results</dc:subject>
</entry>
<entry>
<id>https://www.globenewswire.com/news-release/2024/10/29/2971221/0/en/Clover-Health-to-Participate-in-Upcoming-Investor-Conferences.html</id>
<title
type="text">Clover Health to Participate in Upcoming Investor Conferences</title>
<published>2024-10-29T20:05:00Z</published>
<updated>2024-11-13T20:20:28Z</updated>
<link
rel="alternate"
href="https://www.globenewswire.com/news-release/2024/10/29/2971221/0/en/Clover-Health-to-Participate-in-Upcoming-Investor-Conferences.html" />
<category
term="Nasdaq:CLOV"
scheme="https://www.globenewswire.com/rss/stock" />
<category
term="US18914F1030"
scheme="https://www.globenewswire.com/rss/ISIN" />
<content
type="html"><![CDATA[<p>FRANKLIN, Tenn., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced its participation in the following investor conferences:</p>]]></content>
<dc:identifier>2971221</dc:identifier>
<dc:language>en</dc:language>
<dc:publisher>GlobeNewswire Inc.</dc:publisher>
<dc:contributor>Clover Health Investments, Corp.</dc:contributor>
<dc:modified>Tue, 29 Oct 2024 20:05 GMT</dc:modified>
<dc:subject>Calendar of Events</dc:subject>
</entry>
<entry>
<id>https://www.globenewswire.com/news-release/2024/10/23/2968173/0/en/Clover-Health-to-Report-Third-Quarter-2024-Financial-Results-on-November-6.html</id>
<title
type="text">Clover Health to Report Third Quarter 2024 Financial Results on November 6</title>
<published>2024-10-23T20:05:00Z</published>
<updated>2024-11-13T20:20:28Z</updated>
<link
rel="alternate"
href="https://www.globenewswire.com/news-release/2024/10/23/2968173/0/en/Clover-Health-to-Report-Third-Quarter-2024-Financial-Results-on-November-6.html" />
<category
term="Nasdaq:CLOV"
scheme="https://www.globenewswire.com/rss/stock" />
<category
term="US18914F1030"
scheme="https://www.globenewswire.com/rss/ISIN" />
<content
type="html"><![CDATA[<p align="left">FRANKLIN, Tenn., Oct. 23, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover Health”), today announced that it will report third quarter 2024 financial results after market close on Wednesday, November 6, 2024. Management will host a conference call and webcast at 5:00 p.m. Eastern Time on November 6, 2024, to discuss Clover Health’s third quarter 2024 business and financial results.</p>]]></content>
<dc:identifier>2968173</dc:identifier>
<dc:language>en</dc:language>
<dc:publisher>GlobeNewswire Inc.</dc:publisher>
<dc:contributor>Clover Health Investments, Corp.</dc:contributor>
<dc:modified>Wed, 23 Oct 2024 20:05 GMT</dc:modified>
<dc:subject>Conference Calls/ Webcasts</dc:subject>
</entry>
<entry>
<id>https://www.globenewswire.com/news-release/2024/10/15/2963341/0/en/2025-Clover-Health-Medicare-Advantage-Benefits-Demonstrate-Commitment-to-New-Jersey-Seniors.html</id>
<title
type="text">2025 Clover Health Medicare Advantage Benefits Demonstrate Commitment to New Jersey Seniors</title>
<published>2024-10-15T13:15:00Z</published>
<updated>2024-11-13T20:20:28Z</updated>
<link
rel="alternate"
href="https://www.globenewswire.com/news-release/2024/10/15/2963341/0/en/2025-Clover-Health-Medicare-Advantage-Benefits-Demonstrate-Commitment-to-New-Jersey-Seniors.html" />
<category
term="Nasdaq:CLOV"
scheme="https://www.globenewswire.com/rss/stock" />
<category
term="US18914F1030"
scheme="https://www.globenewswire.com/rss/ISIN" />
<content
type="html"><![CDATA[Company’s affordable, benefit-rich flagship PPO plans now have 4 Star rating <pre>Company’s affordable, benefit-rich flagship PPO plans now have 4 Star rating</pre>]]></content>
<dc:identifier>2963341</dc:identifier>
<dc:language>en</dc:language>
<dc:publisher>GlobeNewswire Inc.</dc:publisher>
<dc:contributor>Clover Health Investments, Corp.</dc:contributor>
<dc:modified>Tue, 15 Oct 2024 13:15 GMT</dc:modified>
<dc:subject>Health</dc:subject>
</entry>
<entry>
<id>https://www.globenewswire.com/news-release/2024/10/10/2961727/0/en/Clover-Health-PPO-Medicare-Advantage-Plans-Earn-4-Star-Rating-for-2025.html</id>
<title
type="text">Clover Health PPO Medicare Advantage Plans Earn 4 Star Rating for 2025</title>
<published>2024-10-10T21:03:45Z</published>
<updated>2024-11-13T20:20:28Z</updated>
<link
rel="alternate"
href="https://www.globenewswire.com/news-release/2024/10/10/2961727/0/en/Clover-Health-PPO-Medicare-Advantage-Plans-Earn-4-Star-Rating-for-2025.html" />
<category
term="Nasdaq:CLOV"
scheme="https://www.globenewswire.com/rss/stock" />
<category
term="US18914F1030"
scheme="https://www.globenewswire.com/rss/ISIN" />
<content
type="html"><![CDATA[Overall Star rating performance increase was driven by exceptional performance on healthcare quality measures, Medication Adherence and Member Experience <pre>Overall Star rating performance increase was driven by exceptional performance on healthcare quality measures, Medication Adherence and Member Experience</pre>]]></content>
<dc:identifier>2961727</dc:identifier>
<dc:language>en</dc:language>
<dc:publisher>GlobeNewswire Inc.</dc:publisher>
<dc:contributor>Clover Health Investments, Corp.</dc:contributor>
<dc:modified>Thu, 10 Oct 2024 21:04 GMT</dc:modified>
<dc:subject>Product / Services Announcement</dc:subject>
</entry>
<entry>
<id>https://www.globenewswire.com/news-release/2024/10/08/2959513/0/en/Counterpart-Health-Names-David-Tsay-M-D-Ph-D-as-Chief-Medical-Officer.html</id>
<title
type="text">Counterpart Health Names David Tsay M.D., Ph.D as Chief Medical Officer</title>
<published>2024-10-08T10:15:00Z</published>
<updated>2024-11-13T20:20:28Z</updated>
<link
rel="alternate"
href="https://www.globenewswire.com/news-release/2024/10/08/2959513/0/en/Counterpart-Health-Names-David-Tsay-M-D-Ph-D-as-Chief-Medical-Officer.html" />
<category
term="Nasdaq:CLOV"
scheme="https://www.globenewswire.com/rss/stock" />
<category
term="US18914F1030"
scheme="https://www.globenewswire.com/rss/ISIN" />
<content
type="html"><![CDATA[Dr. Tsay Brings Unique Expertise in AI, Digital Health, and Clinical Innovation to Counterpart Health <pre>Dr. Tsay Brings Unique Expertise in AI, Digital Health, and Clinical Innovation to Counterpart Health</pre>]]></content>
<dc:identifier>2959513</dc:identifier>
<dc:language>en</dc:language>
<dc:publisher>GlobeNewswire Inc.</dc:publisher>
<dc:contributor>Clover Health Investments, Corp.</dc:contributor>
<dc:modified>Tue, 08 Oct 2024 10:15 GMT</dc:modified>
<dc:subject>Directors and Officers</dc:subject>
</entry>
<entry>
<id>https://www.globenewswire.com/news-release/2024/09/26/2954122/0/en/Clover-Health-Appoints-Seasoned-Healthcare-Executive-as-Chief-Operating-Officer-for-Medicare-Advantage-Operations.html</id>
<title
type="text">Clover Health Appoints Seasoned Healthcare Executive as Chief Operating Officer for Medicare Advantage Operations</title>
<published>2024-09-26T20:00:00Z</published>
<updated>2024-11-13T20:20:28Z</updated>
<link
rel="alternate"
href="https://www.globenewswire.com/news-release/2024/09/26/2954122/0/en/Clover-Health-Appoints-Seasoned-Healthcare-Executive-as-Chief-Operating-Officer-for-Medicare-Advantage-Operations.html" />
<category
term="Nasdaq:CLOV"
scheme="https://www.globenewswire.com/rss/stock" />
<category
term="US18914F1030"
scheme="https://www.globenewswire.com/rss/ISIN" />
<content
type="html"><![CDATA[New Jersey Native Joseph Brand to Lead Operational Efficiency and Innovation in MA Operations, Enhancing Care for Physicians and Patients <pre>New Jersey Native Joseph Brand to Lead Operational Efficiency and Innovation in MA Operations, Enhancing Care for Physicians and Patients</pre>]]></content>
<dc:identifier>2954122</dc:identifier>
<dc:language>en</dc:language>
<dc:publisher>GlobeNewswire Inc.</dc:publisher>
<dc:contributor>Clover Health Investments, Corp.</dc:contributor>
<dc:modified>Thu, 26 Sep 2024 20:00 GMT</dc:modified>
<dc:subject>Directors and Officers</dc:subject>
</entry>
<entry>
<id>https://www.globenewswire.com/news-release/2024/09/03/2940072/0/en/The-Iowa-Clinic-Signs-Multi-Year-Agreement-with-Counterpart-Health-to-Deploy-Proven-AI-Technology-to-Hundreds-of-Providers-Across-the-Midwest.html</id>
<title
type="text">The Iowa Clinic Signs Multi-Year Agreement with Counterpart Health to Deploy Proven AI Technology to Hundreds of Providers Across the Midwest</title>
<published>2024-09-03T20:05:00Z</published>
<updated>2024-11-13T20:20:28Z</updated>
<link
rel="alternate"
href="https://www.globenewswire.com/news-release/2024/09/03/2940072/0/en/The-Iowa-Clinic-Signs-Multi-Year-Agreement-with-Counterpart-Health-to-Deploy-Proven-AI-Technology-to-Hundreds-of-Providers-Across-the-Midwest.html" />
<category
term="Nasdaq:CLOV"
scheme="https://www.globenewswire.com/rss/stock" />
<category
term="US18914F1030"
scheme="https://www.globenewswire.com/rss/ISIN" />
<content
type="html"><![CDATA[<p align="left">FRANKLIN, Tenn., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Today, <a href="https://www.globenewswire.com/Tracker?data=OW86Z_u1GlHV5j8uUDnJGjTK9q4uucjx9gukhoxsFB-J-pu6NaF9P5ZjtAnav2nyKRJ5ir4lU3OcPm_tp8jpN68ViIFbF48xWOn6Q0cNgZ5P1JWbJYptEEimByNPObqC" rel="nofollow" target="_blank" title=""><u>Counterpart Health, Inc</u></a>. (“Counterpart”), a leading AI-powered physician enablement platform, announced a multi-year agreement with <a href="https://www.globenewswire.com/Tracker?data=sd431ESzER0Wp8Zi4sDLIU9_cUmpBNS8MeiaehYHSXIFLMa6xAOA-GZFEeyr342OHH72jkDdZ93EiSQtDbA0zcJwMwZrAGJdSj4mFpoumGk=" rel="nofollow" target="_blank" title=""><u>The Iowa Clinic, P.C</u></a>., one of the most highly regarded multispecialty healthcare groups in the United States. This deal positions The Iowa Clinic as one of Counterpart's anchor customers in the Midwest, as Counterpart drives a broader strategic expansion across the country. Counterpart is a subsidiary of Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover Health”).<br></p>]]></content>
<dc:identifier>2940072</dc:identifier>
<dc:language>en</dc:language>
<dc:publisher>GlobeNewswire Inc.</dc:publisher>
<dc:contributor>Clover Health Investments, Corp.</dc:contributor>
<dc:modified>Tue, 03 Sep 2024 20:05 GMT</dc:modified>
<dc:subject>Business Contracts</dc:subject>
<dc:subject>Health</dc:subject>
</entry>
<entry>
<id>https://www.globenewswire.com/news-release/2024/08/22/2934249/0/en/Thomas-L-Tran-Former-Chief-Financial-Officer-of-Molina-Healthcare-Joins-Clover-Health-s-Board-of-Directors.html</id>
<title
type="text">Thomas L. Tran, Former Chief Financial Officer of Molina Healthcare, Joins Clover Health’s Board of Directors</title>
<published>2024-08-22T13:00:00Z</published>
<updated>2024-11-13T20:20:28Z</updated>
<link
rel="alternate"
href="https://www.globenewswire.com/news-release/2024/08/22/2934249/0/en/Thomas-L-Tran-Former-Chief-Financial-Officer-of-Molina-Healthcare-Joins-Clover-Health-s-Board-of-Directors.html" />
<category
term="Nasdaq:CLOV"
scheme="https://www.globenewswire.com/rss/stock" />
<category
term="US18914F1030"
scheme="https://www.globenewswire.com/rss/ISIN" />
<content
type="html"><![CDATA[<p>FRANKLIN, Tenn., Aug. 22, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement technology company committed to bringing access to great healthcare to everyone on Medicare, today announced it has appointed Thomas L. Tran to the Company’s Board of Directors (the "Board"), and as a member of the Audit Committee.<br></p>]]></content>
<dc:identifier>2934249</dc:identifier>
<dc:language>en</dc:language>
<dc:publisher>GlobeNewswire Inc.</dc:publisher>
<dc:contributor>Clover Health Investments, Corp.</dc:contributor>
<dc:modified>Thu, 22 Aug 2024 13:00 GMT</dc:modified>
<dc:subject>Directors and Officers</dc:subject>
</entry>
<entry>
<id>https://www.globenewswire.com/news-release/2024/08/21/2933837/0/en/Clover-Health-to-Participate-in-Upcoming-2024-Wells-Fargo-Healthcare-Conference.html</id>
<title
type="text">Clover Health to Participate in Upcoming 2024 Wells Fargo Healthcare Conference</title>
<published>2024-08-21T20:05:00Z</published>
<updated>2024-11-13T20:20:28Z</updated>
<link
rel="alternate"
href="https://www.globenewswire.com/news-release/2024/08/21/2933837/0/en/Clover-Health-to-Participate-in-Upcoming-2024-Wells-Fargo-Healthcare-Conference.html" />
<category
term="Nasdaq:CLOV"
scheme="https://www.globenewswire.com/rss/stock" />
<category
term="US18914F1030"
scheme="https://www.globenewswire.com/rss/ISIN" />
<content
type="html"><![CDATA[<p>FRANKLIN, Tenn., Aug. 21, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement technology company committed to bringing access to great healthcare to everyone on Medicare, today announced that its Chief Financial Officer, Peter Kuipers, will present at the 2024 Wells Fargo Healthcare Conference on Wednesday, September 4, 2024, at 4:30 p.m. Eastern Time.<br></p>]]></content>
<dc:identifier>2933837</dc:identifier>
<dc:language>en</dc:language>
<dc:publisher>GlobeNewswire Inc.</dc:publisher>
<dc:contributor>Clover Health Investments, Corp.</dc:contributor>
<dc:modified>Wed, 21 Aug 2024 20:05 GMT</dc:modified>
<dc:subject>Calendar of Events</dc:subject>
<dc:subject>Conference Calls/ Webcasts</dc:subject>
</entry>
<entry>
<id>https://www.globenewswire.com/news-release/2024/08/05/2924608/0/en/Clover-Health-Reports-Second-Quarter-2024-Financial-Results-Improves-Full-Year-Guidance-on-Strong-Performance.html</id>
<title
type="text">Clover Health Reports Second Quarter 2024 Financial Results; Improves Full-Year Guidance on Strong Performance</title>
<published>2024-08-05T20:05:00Z</published>
<updated>2024-11-13T20:20:28Z</updated>
<link
rel="alternate"
href="https://www.globenewswire.com/news-release/2024/08/05/2924608/0/en/Clover-Health-Reports-Second-Quarter-2024-Financial-Results-Improves-Full-Year-Guidance-on-Strong-Performance.html" />
<category
term="Nasdaq:CLOV"
scheme="https://www.globenewswire.com/rss/stock" />
<category
term="US18914F1030"
scheme="https://www.globenewswire.com/rss/ISIN" />
<content
type="html"><![CDATA[<p align="center"><em>Total Revenue growth for the Second Quarter of 2024 of 11% year-over-year</em><br></p>]]></content>
<dc:identifier>2924608</dc:identifier>
<dc:language>en</dc:language>
<dc:publisher>GlobeNewswire Inc.</dc:publisher>
<dc:contributor>Clover Health Investments, Corp.</dc:contributor>
<dc:modified>Mon, 05 Aug 2024 20:05 GMT</dc:modified>
<dc:subject>Calendar of Events</dc:subject>
<dc:subject>Earnings Releases and Operating Results</dc:subject>
<dc:subject>Health</dc:subject>
<dc:subject>Conference Calls/ Webcasts</dc:subject>
</entry>
<entry>
<id>https://www.globenewswire.com/news-release/2024/07/24/2918355/0/en/Clover-Health-to-Participate-in-Upcoming-2024-KeyBanc-Technology-Leadership-Forum-and-Canaccord-Genuity-44th-Annual-Growth-Conference.html</id>
<title
type="text">Clover Health to Participate in Upcoming 2024 KeyBanc Technology Leadership Forum and Canaccord Genuity 44th Annual Growth Conference</title>
<published>2024-07-24T20:05:00Z</published>
<updated>2024-11-13T20:20:28Z</updated>
<link
rel="alternate"
href="https://www.globenewswire.com/news-release/2024/07/24/2918355/0/en/Clover-Health-to-Participate-in-Upcoming-2024-KeyBanc-Technology-Leadership-Forum-and-Canaccord-Genuity-44th-Annual-Growth-Conference.html" />
<category
term="Nasdaq:CLOV"
scheme="https://www.globenewswire.com/rss/stock" />
<category
term="US18914F1030"
scheme="https://www.globenewswire.com/rss/ISIN" />
<content
type="html"><![CDATA[<p>FRANKLIN, Tenn., July 24, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement technology company committed to bringing access to great healthcare to everyone on Medicare, today announced its participation in the following investor conferences:<br></p>]]></content>
<dc:identifier>2918355</dc:identifier>
<dc:language>en</dc:language>
<dc:publisher>GlobeNewswire Inc.</dc:publisher>
<dc:contributor>Clover Health Investments, Corp.</dc:contributor>
<dc:modified>Wed, 24 Jul 2024 20:05 GMT</dc:modified>
<dc:subject>Calendar of Events</dc:subject>
</entry>
<entry>
<id>https://www.globenewswire.com/news-release/2024/07/22/2916826/0/en/Clover-Health-to-Report-Second-Quarter-2024-Financial-Results-on-August-5.html</id>
<title
type="text">Clover Health to Report Second Quarter 2024 Financial Results on August 5</title>
<published>2024-07-22T20:05:00Z</published>
<updated>2024-11-13T20:20:28Z</updated>
<link
rel="alternate"
href="https://www.globenewswire.com/news-release/2024/07/22/2916826/0/en/Clover-Health-to-Report-Second-Quarter-2024-Financial-Results-on-August-5.html" />
<category
term="Nasdaq:CLOV"
scheme="https://www.globenewswire.com/rss/stock" />
<category
term="US18914F1030"
scheme="https://www.globenewswire.com/rss/ISIN" />
<content
type="html"><![CDATA[<p>FRANKLIN, Tenn., July 22, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover Health”), a physician enablement technology company committed to bringing access to great healthcare to everyone on Medicare, today announced that it will report second quarter 2024 financial results after market close on Monday, August 5, 2024. Management will host a conference call and webcast at 5:00 p.m. Eastern Time on August 5, 2024, to discuss Clover Health’s business and financial results.<br></p>]]></content>
<dc:identifier>2916826</dc:identifier>
<dc:language>en</dc:language>
<dc:publisher>GlobeNewswire Inc.</dc:publisher>
<dc:contributor>Clover Health Investments, Corp.</dc:contributor>
<dc:modified>Mon, 22 Jul 2024 20:05 GMT</dc:modified>
<dc:subject>Calendar of Events</dc:subject>
<dc:subject>Conference Calls/ Webcasts</dc:subject>
</entry>
<entry>
<id>https://www.globenewswire.com/news-release/2024/06/26/2904822/0/en/Clover-Health-Regains-Compliance-with-NASDAQ-Minimum-Bid-Price-Requirement.html</id>
<title
type="text">Clover Health Regains Compliance with NASDAQ Minimum Bid Price Requirement</title>
<published>2024-06-26T20:15:00Z</published>
<updated>2024-11-13T20:20:28Z</updated>
<link
rel="alternate"
href="https://www.globenewswire.com/news-release/2024/06/26/2904822/0/en/Clover-Health-Regains-Compliance-with-NASDAQ-Minimum-Bid-Price-Requirement.html" />
<category
term="Nasdaq:CLOV"
scheme="https://www.globenewswire.com/rss/stock" />
<category
term="US18914F1030"
scheme="https://www.globenewswire.com/rss/ISIN" />
<content
type="html"><![CDATA[<p>FRANKLIN, Tenn., June 26, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement technology company committed to bringing access to great healthcare to everyone on Medicare, today announced that it has received formal notice from The Nasdaq Stock Market, LLC ("Nasdaq") stating that the Company has regained compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5450(a)(1).</p>]]></content>
<dc:identifier>2904822</dc:identifier>
<dc:language>en</dc:language>
<dc:publisher>GlobeNewswire Inc.</dc:publisher>
<dc:contributor>Clover Health Investments, Corp.</dc:contributor>
<dc:modified>Wed, 26 Jun 2024 20:15 GMT</dc:modified>
<dc:subject>Health</dc:subject>
<dc:subject>Major shareholder announcements</dc:subject>
</entry>
<entry>
<id>https://www.globenewswire.com/news-release/2024/06/14/2898994/0/en/CMS-Improves-Star-Ratings-to-3-5-Stars-for-Clover-Health-PPO-Medicare-Advantage-Plans-for-2025-Payment-Year.html</id>
<title
type="text">CMS Improves Star Ratings to 3.5 Stars for Clover Health PPO Medicare Advantage Plans for 2025 Payment Year</title>
<published>2024-06-14T13:00:00Z</published>
<updated>2024-11-13T20:20:28Z</updated>
<link
rel="alternate"
href="https://www.globenewswire.com/news-release/2024/06/14/2898994/0/en/CMS-Improves-Star-Ratings-to-3-5-Stars-for-Clover-Health-PPO-Medicare-Advantage-Plans-for-2025-Payment-Year.html" />
<category
term="Nasdaq:CLOV"
scheme="https://www.globenewswire.com/rss/stock" />
<category
term="US18914F1030"
scheme="https://www.globenewswire.com/rss/ISIN" />
<content
type="html"><![CDATA[The Company previously communicated that CMS had calculated a rating of 3.0 Stars for its PPO plans, impacting payment year 2025. As a result of a recent rating recalculation, CMS has improved that rating to 3.5 Stars for 2025 payment year <pre>The Company previously communicated that CMS had calculated a rating of 3.0 Stars for its PPO plans, impacting payment year 2025. As a result of a recent rating recalculation, CMS has improved that rating to 3.5 Stars for 2025 payment year</pre>]]></content>
<dc:identifier>2898994</dc:identifier>
<dc:language>en</dc:language>
<dc:publisher>GlobeNewswire Inc.</dc:publisher>
<dc:contributor>Clover Health Investments, Corp.</dc:contributor>
<dc:modified>Fri, 14 Jun 2024 13:00 GMT</dc:modified>
<dc:subject>Major shareholder announcements</dc:subject>
</entry>
<entry>
<id>https://www.globenewswire.com/news-release/2024/05/29/2889798/0/en/Clover-Health-Announces-Counterpart-Health-a-New-SaaS-and-Tech-Enabled-Services-Solution-to-Bring-the-Power-of-CA-Technology-to-all-Medicare-Advantage-Payors-and-Providers.html</id>
<title
type="text">Clover Health Announces Counterpart Health, a New SaaS and Tech Enabled Services Solution to Bring the Power of CA Technology to all Medicare Advantage Payors and Providers</title>
<published>2024-05-29T12:00:00Z</published>
<updated>2024-11-13T20:20:28Z</updated>
<link
rel="alternate"
href="https://www.globenewswire.com/news-release/2024/05/29/2889798/0/en/Clover-Health-Announces-Counterpart-Health-a-New-SaaS-and-Tech-Enabled-Services-Solution-to-Bring-the-Power-of-CA-Technology-to-all-Medicare-Advantage-Payors-and-Providers.html" />
<category
term="Nasdaq:CLOV"
scheme="https://www.globenewswire.com/rss/stock" />
<category
term="US18914F1030"
scheme="https://www.globenewswire.com/rss/ISIN" />
<content
type="html"><![CDATA[<p>FRANKLIN, Tenn., May 29, 2024 (GLOBE NEWSWIRE) -- <strong>Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”)</strong>, a physician enablement technology company committed to bringing access to great healthcare to everyone on Medicare, is excited to announce that its flagship clinical decision support tool, Clover Assistant, is now generally available for external payors and providers under the brand name Counterpart Assistant (“CA”). This strategic move with Counterpart Health, a subsidiary of Clover Health, aims to extend the benefits of data-driven proven technology, personalized care to a wider audience, enabling enhanced patient outcomes and reduced healthcare costs across the nation.<br></p>]]></content>
<dc:identifier>2889798</dc:identifier>
<dc:language>en</dc:language>
<dc:publisher>GlobeNewswire Inc.</dc:publisher>
<dc:contributor>Clover Health Investments, Corp.</dc:contributor>
<dc:modified>Wed, 29 May 2024 12:01 GMT</dc:modified>
<dc:subject>Health</dc:subject>
<dc:subject>Product / Services Announcement</dc:subject>
</entry>
<entry>
<id>https://www.globenewswire.com/news-release/2024/05/07/2877214/0/en/Clover-Health-Reports-Strong-First-Quarter-2024-Financial-Results-Improves-Guidance-to-Target-Full-Year-2024-Adjusted-EBITDA-Profitability.html</id>
<title
type="text">Clover Health Reports Strong First Quarter 2024 Financial Results; Improves Guidance to Target Full-Year 2024 Adjusted EBITDA Profitability</title>
<published>2024-05-07T20:05:00Z</published>
<updated>2024-11-13T20:20:28Z</updated>
<link
rel="alternate"
href="https://www.globenewswire.com/news-release/2024/05/07/2877214/0/en/Clover-Health-Reports-Strong-First-Quarter-2024-Financial-Results-Improves-Guidance-to-Target-Full-Year-2024-Adjusted-EBITDA-Profitability.html" />
<category
term="Nasdaq:CLOV"
scheme="https://www.globenewswire.com/rss/stock" />
<category
term="US18914F1030"
scheme="https://www.globenewswire.com/rss/ISIN" />
<content
type="html"><![CDATA[<p align="center"><em>First Quarter 2024 Insurance Revenue growth of 8% year-over-year</em><br></p>]]></content>
<dc:identifier>2877214</dc:identifier>
<dc:language>en</dc:language>
<dc:publisher>GlobeNewswire Inc.</dc:publisher>
<dc:contributor>Clover Health Investments, Corp.</dc:contributor>
<dc:modified>Tue, 07 May 2024 20:05 GMT</dc:modified>
<dc:subject>Earnings Releases and Operating Results</dc:subject>
</entry>
<entry>
<id>https://www.globenewswire.com/news-release/2024/05/01/2873624/0/en/Clover-Health-to-Participate-at-Bank-of-America-2024-Healthcare-Conference-and-Present-at-2024-Leerink-Partners-Healthcare-Crossroads-Conference.html</id>
<title
type="text">Clover Health to Participate at Bank of America 2024 Healthcare Conference and Present at 2024 Leerink Partners Healthcare Crossroads Conference</title>
<published>2024-05-01T20:05:00Z</published>
<updated>2024-11-13T20:20:28Z</updated>
<link
rel="alternate"
href="https://www.globenewswire.com/news-release/2024/05/01/2873624/0/en/Clover-Health-to-Participate-at-Bank-of-America-2024-Healthcare-Conference-and-Present-at-2024-Leerink-Partners-Healthcare-Crossroads-Conference.html" />
<category
term="Nasdaq:CLOV"
scheme="https://www.globenewswire.com/rss/stock" />
<category
term="US18914F1030"
scheme="https://www.globenewswire.com/rss/ISIN" />
<content
type="html"><![CDATA[<p>FRANKLIN, Tenn., May 01, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement technology company committed to bringing access to great healthcare to everyone on Medicare, today announced its participation in the following investor conferences:<br></p>]]></content>
<dc:identifier>2873624</dc:identifier>
<dc:language>en</dc:language>
<dc:publisher>GlobeNewswire Inc.</dc:publisher>
<dc:contributor>Clover Health Investments, Corp.</dc:contributor>
<dc:modified>Wed, 01 May 2024 20:05 GMT</dc:modified>
<dc:subject>Calendar of Events</dc:subject>
<dc:subject>Health</dc:subject>
</entry>
<entry>
<id>https://www.globenewswire.com/news-release/2024/04/30/2872800/0/en/Clover-Health-Announces-Inducement-Grant-under-Nasdaq-Listing-Rule-5635-c-4.html</id>
<title
type="text">Clover Health Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)</title>
<published>2024-04-30T20:15:00Z</published>
<updated>2024-11-13T20:20:28Z</updated>
<link
rel="alternate"
href="https://www.globenewswire.com/news-release/2024/04/30/2872800/0/en/Clover-Health-Announces-Inducement-Grant-under-Nasdaq-Listing-Rule-5635-c-4.html" />
<category
term="Nasdaq:CLOV"
scheme="https://www.globenewswire.com/rss/stock" />
<category
term="US18914F1030"
scheme="https://www.globenewswire.com/rss/ISIN" />
<content
type="html"><![CDATA[<p>FRANKLIN, Tenn., April 30, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover” or the “Company”), a physician enablement technology company committed to bringing access to great healthcare to everyone on Medicare, announced today that effective April 29, 2024, the Talent and Compensation Committee of the Company’s Board of Directors granted a restricted stock unit award (the “RSUs”) to Peter Kuipers, who will be the Company’s new Chief Financial Officer effective as of the day after filing of our Quarterly Report on Form 10-Q for the quarter-ended March 31, 2024. The RSUs were granted under the Company’s 2022 Inducement Award Plan (the “Inducement Plan”) and will be subject to the terms and conditions of an award agreement and the Inducement Plan.<br></p>]]></content>
<dc:identifier>2872800</dc:identifier>
<dc:language>en</dc:language>
<dc:publisher>GlobeNewswire Inc.</dc:publisher>
<dc:contributor>Clover Health Investments, Corp.</dc:contributor>
<dc:modified>Tue, 30 Apr 2024 20:15 GMT</dc:modified>
<dc:subject>Major shareholder announcements</dc:subject>
<dc:subject>Exchange announcement</dc:subject>
</entry>
<entry>
<id>https://www.globenewswire.com/news-release/2024/04/23/2868114/0/en/Clover-Health-to-Report-First-Quarter-2024-Financial-Results-on-May-7-2024.html</id>
<title
type="text">Clover Health to Report First Quarter 2024 Financial Results on May 7, 2024</title>
<published>2024-04-23T20:05:00Z</published>
<updated>2024-11-13T20:20:28Z</updated>
<link
rel="alternate"
href="https://www.globenewswire.com/news-release/2024/04/23/2868114/0/en/Clover-Health-to-Report-First-Quarter-2024-Financial-Results-on-May-7-2024.html" />
<category
term="Nasdaq:CLOV"
scheme="https://www.globenewswire.com/rss/stock" />
<category
term="US18914F1030"
scheme="https://www.globenewswire.com/rss/ISIN" />
<content
type="html"><![CDATA[<p>FRANKLIN, Tenn., April 23, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that it will report first quarter 2024 financial results after market close on Tuesday, May 7, 2024. Management will host a conference call and webcast at 5:00 p.m. Eastern Time on May 7, 2024, to discuss the Company’s business and financial results.<br></p>]]></content>
<dc:identifier>2868114</dc:identifier>
<dc:language>en</dc:language>
<dc:publisher>GlobeNewswire Inc.</dc:publisher>
<dc:contributor>Clover Health Investments, Corp.</dc:contributor>
<dc:modified>Tue, 23 Apr 2024 20:05 GMT</dc:modified>
<dc:subject>Calendar of Events</dc:subject>
<dc:subject>Conference Calls/ Webcasts</dc:subject>
</entry>
</feed>